← Back to Search

Re-Connect App for Smoking Cessation

N/A
Recruiting
Led By Bethany Raiff, PhD
Research Sponsored by Rowan University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individuals who report smoking at least 10 cigarettes per day for at least 2 years and are 18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights

Summary

This trial will test if making people use an app to prove they're not smoking works to help them quit.

Who is the study for?
This trial is for adults who have smoked at least 10 cigarettes daily for over 2 years, want to quit smoking (strong desire), can use a smartphone, and speak English. They must not have health issues like severe lung conditions or unmanaged mental health problems.
What is being tested?
The study tests two methods using smartphone apps that reward quitting smoking: one restricts app access unless you prove you're smoke-free, while the other rewards abstinence with more app features.
What are the potential side effects?
There are no direct medical side effects since this trial involves behavior modification through technology rather than medication. However, participants may experience stress or frustration related to quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have smoked 10 cigarettes daily for 2+ years and am 18 or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
7-day point prevalence of self-reported, and CO verified, smoking
Acceptability (RCT, Aim 2)
Duration of Re-Connect Use (RCT, Aim 2)
+3 more
Secondary study objectives
Initial Acceptability
Other study objectives
Smartphone Use Moderators

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Abstinent Contingent (AC) Re-ConnectExperimental Treatment1 Intervention
Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO\<=6ppm).
Group II: Submission Contingent (SC) Re-ConnectActive Control1 Intervention
Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence.

Find a Location

Who is running the clinical trial?

Rowan UniversityLead Sponsor
23 Previous Clinical Trials
2,783 Total Patients Enrolled
University of KentuckyOTHER
189 Previous Clinical Trials
220,602 Total Patients Enrolled
Bethany Raiff, PhDPrincipal InvestigatorRowan University
1 Previous Clinical Trials
52 Total Patients Enrolled

Media Library

Abstinent Contingent (AC) Re-Connect Clinical Trial Eligibility Overview. Trial Name: NCT05224154 — N/A
Acceptability of Health Care Research Study Groups: Submission Contingent (SC) Re-Connect, Abstinent Contingent (AC) Re-Connect
Acceptability of Health Care Clinical Trial 2023: Abstinent Contingent (AC) Re-Connect Highlights & Side Effects. Trial Name: NCT05224154 — N/A
Abstinent Contingent (AC) Re-Connect 2023 Treatment Timeline for Medical Study. Trial Name: NCT05224154 — N/A
~13 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top